 |
Leading The Way
Established 2003, Scansol® leads
the way in providing high quality primary care screening
for skin
cancer in the
UK.
We
operate The MOLE Clinic® - the only Independent Acute
Hospital in the UK registered by the Care
Quality Commission exclusively for skin cancer screening,
diagnosis and treatment.
If you are interested in being screened for skin cancer, please
visit The
MOLE Clinic®.
We are also sole providers of TeleDerm® - an innovative
tele-medicine service
which offers GPs rapid, specialist investigation of atypical
moles.
If you are a GP,
please visit TeleDerm®.
|
|
The
GPs' Choice
Scansol® is committed to
delivering services which are evidence-based, clinically
proven and meet or exceed UK Department of Health Standards.
We guarantee:
• The most effective treatment in line with National
Institute for Clinical Excellence Guidelines.
• Safe and patient-focused clinical services
• Good clinical governance
• A well designed and maintained care environment.
It
is our commitment to quality that makes Scansol® the GPs’ choice for
skin cancer screening. |
|
| |
Company News |
| |
February 2010
Scansol® wins Patient Safety
in Primary Care Award 2010.
October
2009
BMI Hospital Ridgeway launches MOLE
Clinic in partnership with Scansol®.
June 2009
Care
Quality Commission praise Scansol® Electronic
Patient Record
as example of 'commendable practice'.
May 2009
Scansol® MD, nominated as finalist in Laing Buisson Healthcare Awards
2009 for 'Entrepreneurial Achievement'.
April
2009
TeleDerm® commissioned
by NHS following successful pilot.
Feb 2009
Scansol® nominated
as finalist in HealthInvestor Awards 2009
for 'Diagnostic Provider of the
Year'.
Oct 2008
TeleDerm® piloted by NHS
Sept 2008
Care
Quality
Commission register Scansol® as Independent
Acute Hospital.
|
|
|
|
